IRIS
GHISELLI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.194
EU - Europa 3.616
AS - Asia 3.461
SA - Sud America 751
AF - Africa 226
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.265
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.061
SG - Singapore 1.310
RU - Federazione Russa 634
UA - Ucraina 626
VN - Vietnam 624
BR - Brasile 575
CN - Cina 525
IT - Italia 389
DE - Germania 351
SE - Svezia 346
IE - Irlanda 331
TR - Turchia 282
HK - Hong Kong 264
FR - Francia 248
DK - Danimarca 234
FI - Finlandia 213
KR - Corea 124
GB - Regno Unito 118
CI - Costa d'Avorio 113
IN - India 66
AR - Argentina 58
MX - Messico 55
CA - Canada 52
BD - Bangladesh 48
IQ - Iraq 36
ZA - Sudafrica 34
MA - Marocco 33
CO - Colombia 30
JP - Giappone 29
EC - Ecuador 27
NL - Olanda 25
ID - Indonesia 22
PL - Polonia 21
PK - Pakistan 19
UZ - Uzbekistan 18
VE - Venezuela 18
BE - Belgio 16
ES - Italia 14
AT - Austria 13
MY - Malesia 13
CL - Cile 12
PH - Filippine 12
PY - Paraguay 12
OM - Oman 9
PE - Perù 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
RO - Romania 8
SA - Arabia Saudita 8
EG - Egitto 7
JO - Giordania 7
UY - Uruguay 7
CR - Costa Rica 6
ET - Etiopia 6
KE - Kenya 6
KZ - Kazakistan 6
LT - Lituania 6
DO - Repubblica Dominicana 5
AU - Australia 4
BG - Bulgaria 4
DZ - Algeria 4
EU - Europa 4
PA - Panama 4
PS - Palestinian Territory 4
AL - Albania 3
AZ - Azerbaigian 3
HR - Croazia 3
IR - Iran 3
LB - Libano 3
SN - Senegal 3
AO - Angola 2
BO - Bolivia 2
CG - Congo 2
CY - Cipro 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GA - Gabon 2
KI - Kiribati 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CV - Capo Verde 1
DM - Dominica 1
FJ - Figi 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
Totale 15.251
Salva come PNG Salva come JPEG
Città #
Ashburn 1.142
Singapore 793
Jacksonville 623
Chandler 568
Fairfield 442
Dallas 391
San Jose 346
Dublin 331
Boardman 293
Hong Kong 254
Wilmington 246
Woodbridge 225
New York 214
Ho Chi Minh City 212
Seattle 189
Houston 172
Moscow 154
Hanoi 148
Ann Arbor 139
Beijing 136
Lawrence 131
Princeton 131
San Mateo 127
Cambridge 119
Lauterbourg 115
The Dalles 115
Abidjan 113
Los Angeles 94
Hefei 81
Des Moines 70
Munich 68
Turin 63
Buffalo 60
San Diego 51
Helsinki 50
São Paulo 50
Centro 49
Turku 44
Orem 39
Da Nang 32
Santa Clara 27
London 26
Mexico City 24
Guangzhou 23
Denver 22
Chicago 21
Council Bluffs 21
Haiphong 21
Johannesburg 21
Tokyo 21
Shanghai 20
Montreal 19
Chennai 18
Tashkent 18
Warsaw 18
Porto 17
Rome 17
Baghdad 16
Brasília 16
Atlanta 15
Brussels 15
Nuremberg 14
Ottawa 14
Rio de Janeiro 14
Izmir 13
Norwalk 13
Pune 13
Biên Hòa 12
Columbus 12
Manchester 12
Redmond 12
Belo Horizonte 11
Brooklyn 11
Buenos Aires 11
Guayaquil 11
Washington 11
Wuhan 11
Amsterdam 10
Ancona 10
Campinas 10
Falls Church 10
Fermo 10
Jakarta 10
Kilburn 10
Poplar 10
Ankara 9
Can Tho 9
Karachi 9
Phoenix 9
Salt Lake City 9
Stockholm 9
Curitiba 8
Dhaka 8
Dronten 8
Hải Dương 8
Mumbai 8
Boston 7
Caracas 7
Montevideo 7
Muscat 7
Totale 9.433
Salva come PNG Salva come JPEG
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 329
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 260
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 229
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 205
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 198
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 190
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 179
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 177
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 174
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 166
Anastomotic healing in a rat model of peritonitis after non-steroidal anti-inflammatory drug administration. 164
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 162
Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy 162
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 153
Attività ed espressione della ossido-nitrico sintetasi nella vescica di ratti sottoposti a neuromodulazione sacrale 152
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 151
Is the bipolar vessel sealer device an effective tool in robotic surgery? A retrospective analysis of our experience and a meta-analysis of the literature about different robotic procedures by investigating operative data and post-operative course 149
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 145
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 144
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 144
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 144
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 144
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 144
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 141
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 139
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 139
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 136
Transanal endoscopic microsurgery: indications, tips and long-term results. A single center experience 136
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 135
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 134
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 134
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 133
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 132
Increase of n-NOS and i-NOS in Rat Colon After Sacral Neuromodulation 131
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 131
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 129
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 129
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 129
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 128
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 127
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 127
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 127
Minimally invasive approach to the adrenal gland in obese patients with Cushing’s syndrome 126
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 125
Transanal endoscopic microsurgery as optimal option in treatment of rare rectal lesions: A single centre experience. 125
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 124
Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation 124
The biocompatibility of dibutyryl chitin in the context of wound dressings. 123
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 123
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 123
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 122
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 121
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 120
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 119
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 119
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 119
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 118
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 117
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 117
Urinary catheters and biofilm formation 116
S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. 116
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 115
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 115
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 114
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 114
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 113
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 113
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 113
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 113
Treatment of rectal cancer by transanal endoscopic microsurgery: experience with 425 patients. 112
LL-37 protects rats against lethal gram-negative sepsis. 111
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 110
S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis. 110
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 109
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 108
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 108
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 106
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 106
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 103
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 101
Totally robotic vs 3D laparoscopic colectomy: A single centers preliminary experience 101
Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation 101
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 100
Transanal endoscopic microsurgery in the treatment of large rectal adenomas. 100
Efficacy of LL-37 and Granulocyte-Colony Stimulating Factor in a Neutropenic Murine Sepsis due to Pseudomonas aeruginosa 97
Nitric Oxide Synthase Expression in Rat Anorectal Tissue after Sacral Neuromodulation 97
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 97
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 97
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 97
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 96
Efficacy of Tachyplesin III, Colistin and Imipenem against Multiresistant Pseudomonas aeruginosa 95
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 95
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. 95
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 95
Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection. 93
Laparoscopic repair of giant Morgagni hernia by direct suturing with V-Loc. 93
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 92
Robotic versus laparoscopic right colectomy for cancer: short-term outcomes and influence of Body Mass Index on conversion rate. 92
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. 90
Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy 90
Totale 12.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.067
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021438 0 0 0 0 0 0 0 0 0 170 198 70
2021/20221.034 73 228 10 52 22 71 45 51 65 125 86 206
2022/20231.767 182 197 138 134 128 211 3 100 443 13 159 59
2023/2024975 175 21 59 145 168 253 17 20 5 13 14 85
2024/20252.426 283 190 131 123 104 159 249 113 455 118 247 254
2025/20265.390 371 479 435 587 569 406 992 584 555 412 0 0
Totale 15.418